Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Matthias Gromeier
Duke University, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
None
Other : Dr. Gromeier is named on IP being used in this grant - licensure is planned for the near future
Dr. Gromeier has IP being used in this grant. There are plans to license this IP in the near future.
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
Glioblastoma multiforme is the most common and most malignant brain tumor. Current treatment is toxic and inadequate. This grant will improve high quality survival by treating with a tumor killing poliovirus and bacterial toxin and by strengthenig the immune system.
Filed on August 07, 2015.
Tell us what you know about Matthias Gromeier's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Matthias Gromeier”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Matthias Gromeier | Duke University | Conflict of Interest | None - IP is unlicensed at this time | Value cannot be readily determined |
| Matthias Gromeier | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Matthias Gromeier | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Matthias Gromeier | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Matthias Gromeier | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.